162
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Systemic Inflammation Index Predicts Poor Clinical Prognosis in Patients with Initially Diagnosed Acute Coronary Syndrome Undergoing Primary Coronary Angiography

, , , , , , & show all
Pages 5205-5219 | Received 14 Aug 2023, Accepted 07 Nov 2023, Published online: 12 Nov 2023

References

  • Roth GA, Johnson C, Abajobir A, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1–25. doi:10.1016/j.jacc.2017.04.052
  • Wang H, Naghavi M, Allen C, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1459–1544.
  • Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204–1222.
  • Ferreira-González I. The epidemiology of coronary heart disease. Rev Espan De Cardiol. 2014;67(2):139–144. doi:10.1016/j.rec.2013.10.002
  • Ralapanawa U, Sivakanesan R. Epidemiology and the magnitude of coronary artery disease and acute coronary syndrome: a narrative review. J Epidemiol Glob Health. 2021;11(2):169–177. doi:10.2991/jegh.k.201217.001
  • Hoole SP, Bambrough P. Recent advances in percutaneous coronary intervention. Heart. 2020;106(18):1380–1386. doi:10.1136/heartjnl-2019-315707
  • Bergmark BA, Mathenge N, Merlini PA, Lawrence-Wright MB, Giugliano RP. Acute coronary syndromes. Lancet. 2022;399(10332):1347–1358. doi:10.1016/S0140-6736(21)02391-6
  • Dagenais GR, Leong DP, Rangarajan S, et al. Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study. Lancet. 2020;395(10226):785–794. doi:10.1016/S0140-6736(19)32007-0
  • Omer MA, Tyler JM, Henry TD, et al. Clinical characteristics and outcomes of STEMI patients with cardiogenic shock and cardiac arrest. JACC Cardiovasc Interv. 2020;13(10):1211–1219. doi:10.1016/j.jcin.2020.04.004
  • Dziedzic EA, Gąsior JS, Tuzimek A, et al. Investigation of the associations of novel inflammatory biomarkers-systemic inflammatory index (SII) and systemic inflammatory response index (SIRI)-with the severity of coronary artery disease and acute coronary syndrome occurrence. Int J Mol Sci. 2022;23(17):9553. doi:10.3390/ijms23179553
  • Shi S, Kong S, Ni W, et al. Association of the systemic immune-inflammation index with outcomes in acute coronary syndrome patients with chronic kidney disease. J Inflamm Res. 2023;16:1343–1356. doi:10.2147/JIR.S397615
  • Arbel Y, Finkelstein A, Halkin A, et al. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis. 2012;225(2):456–460. doi:10.1016/j.atherosclerosis.2012.09.009
  • Wheeler JG, Mussolino ME, Gillum RF, Danesh J. Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individuals. Eur Heart J. 2004;25(15):1287–1292. doi:10.1016/j.ehj.2004.05.002
  • Balta S, Ozturk C. The platelet-lymphocyte ratio: a simple, inexpensive and rapid prognostic marker for cardiovascular events. Platelets. 2015;26(7):680–681. doi:10.3109/09537104.2014.979340
  • Han K, Shi D, Yang L, et al. Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Ann Med. 2022;54(1):1667–1677. doi:10.1080/07853890.2022.2083671
  • Fan Z, Ji H, Li Y, Jian X, Li L, Liu T. Relationship between monocyte-to-lymphocyte ratio and coronary plaque vulnerability in patients with stable angina. Biomark Med. 2017;11(11):979–990. doi:10.2217/bmm-2017-0235
  • Ayça B, Akin F, Çelik Ö, et al. Platelet to lymphocyte ratio as a prognostic marker in primary percutaneous coronary intervention. Platelets. 2015;26(7):638–644. doi:10.3109/09537104.2014.968117
  • Muhmmed Suliman MA, Bahnacy Juma AA, Ali Almadhani AA, Pathare AV, Alkindi SS, Uwe Werner F. Predictive value of neutrophil to lymphocyte ratio in outcomes of patients with acute coronary syndrome. Arch Med Res. 2010;41(8):618–622. doi:10.1016/j.arcmed.2010.11.006
  • Wang X, Hu Y, Luan H, et al. Predictive impact of fibrinogen-to-albumin ratio (FAR) for left ventricular dysfunction in acute coronary syndrome: a cross-sectional study. Eur J Med Res. 2023;28(1):68. doi:10.1186/s40001-023-01029-2
  • Candemir M, Kiziltunç E, Nurkoç S, Şahinarslan A. Relationship between systemic immune-inflammation index (SII) and the severity of stable coronary artery disease. Angiology. 2021;72(6):575–581. doi:10.1177/0003319720987743
  • Erdoğan M, Erdöl MA, Öztürk S, Durmaz T. Systemic immune-inflammation index is a novel marker to predict functionally significant coronary artery stenosis. Biomark Med. 2020;14(16):1553–1561. doi:10.2217/bmm-2020-0274
  • Gok M, Kurtul A. A novel marker for predicting severity of acute pulmonary embolism: systemic immune-inflammation index. Scand Cardiovasc J. 2021;55(2):91–96. doi:10.1080/14017431.2020.1846774
  • Satny M, Hubacek JA, Vrablik M. Statins and Inflammation. Curr Atheroscler Rep. 2021;23(12):80. doi:10.1007/s11883-021-00977-6
  • Koupenova M, Clancy L, Corkrey HA, Freedman JE. Circulating platelets as mediators of immunity, inflammation, and thrombosis. Circ Res. 2018;122(2):337–351. doi:10.1161/CIRCRESAHA.117.310795
  • Pezel T, Unterseeh T, Hovasse T, et al. Phenotypic clustering of patients with newly diagnosed coronary artery disease using cardiovascular magnetic resonance and coronary computed tomography angiography. Front Cardiov Med. 2021;8:760120. doi:10.3389/fcvm.2021.760120
  • Libby P, Tabas I, Fredman G, Fisher EA. Inflammation and its resolution as determinants of acute coronary syndromes. Circ Res. 2014;114(12):1867–1879. doi:10.1161/CIRCRESAHA.114.302699
  • Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54(23):2129–2138. doi:10.1016/j.jacc.2009.09.009
  • Kaptoge S, Di Angelantonio E, Pennells L, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med. 2012;367(14):1310–1320.
  • Eisen A, Giugliano RP, Braunwald E. Updates on acute coronary syndrome: a review. JAMA Cardiol. 2016;1(6):718–730. doi:10.1001/jamacardio.2016.2049
  • Yildiz C, Yuksel Y, Rakici IT, Katkat F, Ayça B, Turhan Çağlar FN. Assessment of systemic immune-inflammation index and systemic inflammation-response index in different coronary artery plaque types. Angiology. 2023;74(6):536–544. doi:10.1177/00033197231158937
  • Xia Y, Xia C, Wu L, Li Z, Li H, Zhang J. Systemic Immune Inflammation Index (SII), System Inflammation Response Index (SIRI) and risk of all-cause mortality and cardiovascular mortality: a 20-year follow-up cohort study of 42,875 US adults. J Clin Med. 2023;12(3):1128. doi:10.3390/jcm12031128
  • Cao Y, Li P, Zhang Y, et al. Association of systemic immune inflammatory index with all-cause and cause-specific mortality in hypertensive individuals: results from NHANES. Front Immunol. 2023;14:1087345. doi:10.3389/fimmu.2023.1087345
  • Li H, Wu X, Bai Y, et al. Physical activity attenuates the associations of systemic immune-inflammation index with total and cause-specific mortality among middle-aged and older populations. Sci Rep. 2021;11(1):12532. doi:10.1038/s41598-021-91324-x
  • Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol. 2009;27:165–197. doi:10.1146/annurev.immunol.021908.132620
  • Medina-Leyte DJ, Zepeda-García O, Domínguez-Pérez M, González-Garrido A, Villarreal-Molina T, Jacobo-Albavera L. Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches. Int J Mol Sci. 2021;22(8):3850. doi:10.3390/ijms22083850
  • Swirski FK, Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science. 2013;339(6116):161–166. doi:10.1126/science.1230719
  • Zernecke A, Bot I, Djalali-Talab Y, et al. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res. 2008;102(2):209–217. doi:10.1161/CIRCRESAHA.107.160697
  • Lowenthal J, Hull SC, Pearson SD. The ethics of early evidence--preparing for a possible breakthrough in Alzheimer’s disease. N Engl J Med. 2012;367(6):488–490. doi:10.1056/NEJMp1203104
  • von Hundelshausen P, Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res. 2007;100(1):27–40. doi:10.1161/01.RES.0000252802.25497.b7
  • Momi S, Falcinelli E, Petito E, Ciarrocca Taranta G, Ossoli A, Gresele P. Matrix metalloproteinase-2 on activated platelets triggers endothelial PAR-1 initiating atherosclerosis. Eur Heart J. 2022;43(6):504–514. doi:10.1093/eurheartj/ehab631
  • Gerrity RG, Naito HK, Richardson M, Schwartz CJ. Dietary induced atherogenesis in swine. Morphology of the intima in prelesion stages. Am J Pathol. 1979;95(3):775–792.
  • Levy WC, Mozaffarian D, Linker DT, et al. The Seattle heart failure model: prediction of survival in heart failure. Circulation. 2006;113(11):1424–1433. doi:10.1161/CIRCULATIONAHA.105.584102
  • Weitz JI. Insights into the role of thrombin in the pathogenesis of recurrent ischaemia after acute coronary syndrome. Thromb Haemost. 2014;112(5):924–931. doi:10.1160/th14-03-0265
  • Athyros VG, Kakafika AI, Karagiannis A, Mikhailidis DP. Do we need to consider inflammatory markers when we treat atherosclerotic disease? Atherosclerosis. 2008;200(1):1–12. doi:10.1016/j.atherosclerosis.2008.02.026
  • Binti NN, Ferdausi N, Anik MEK, Islam LN. Association of albumin, fibrinogen, and modified proteins with acute coronary syndrome. PLoS One. 2022;17(7):e0271882. doi:10.1371/journal.pone.0271882
  • Fan W, Zhang Y, Gao X, et al. the prognostic value of a derived neutrophil-lymphocyte ratio in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Clin Appl Thromb Hemost. 2021;27:10760296211034579. doi:10.1177/10760296211034579
  • Verdoia M, Nardin M, Gioscia R, et al. Higher neutrophil-to-lymphocyte ratio (NLR) increases the risk of suboptimal platelet inhibition and major cardiovascular ischemic events among ACS patients receiving dual antiplatelet therapy with ticagrelor. Vascul Pharmacol. 2020;132:106765. doi:10.1016/j.vph.2020.106765
  • Yang YL, Wu CH, Hsu PF, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50(5):e13230. doi:10.1111/eci.13230
  • Karadeniz F, Karadeniz Y, Altuntaş E. Systemic immune-inflammation index, and neutrophil to-lymphocyte and platelet-to-lymphocyte ratios can predict clinical outcomes in patients with acute coronary syndrome. Cardiovasc J Afr. 2023;34:1–7. doi:10.5830/CVJA-2023-011
  • Mangalesh S, Dudani S, Mahesh NK. Development of a novel inflammatory index to predict coronary artery disease severity in patients with acute coronary syndrome. Angiology. 2023;33197231151564. doi:10.1177/00033197231151564
  • Li YQ, Bai G, Gao Y, et al. The systemic immune inflammatory response index can predict the clinical prognosis of patients with initially diagnosed coronary artery disease. J Inflamm Res. 2023;16:5069–5082. doi:10.2147/JIR.S432506
  • Kwan AC, Wei J, Ouyang D, et al. Sex differences in contributors to coronary microvascular dysfunction. Front Cardiov Med. 2023;10:1085914. doi:10.3389/fcvm.2023.1085914